Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, pso...

Por Burmester, Gerd R, Panaccione, Remo, Gordon, Kenneth B, McIlraith, Melissa J, Lacerda, Ana P M
Publicado em 2013

Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

Por Burmester, Gerd R, Landewé, Robert, Genovese, Mark C, Friedman, Alan W, Pfeifer, Nathan D, Varothai, Nupun A, Lacerda, Ana P
Publicado no Ann Rheum Dis (2017)

A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases

Por Vangeli, Eleni, Bakhshi, Savita, Baker, Anna, Fisher, Abigail, Bucknor, Delaney, Mrowietz, Ulrich, Östör, Andrew J. K., Peyrin-Biroulet, Laurent, Lacerda, Ana P., Weinman, John
Publicado no Adv Ther (2015)